Cargando…
Randomized controlled trial of Hepatitis B virus vaccine in HIV-1-infected patients comparing two different doses
BACKGROUND: Co-infection with hepatitis B virus (HBV) and human immunodeficiency virus (HIV) is not infrequent as both share same route of exposure. The risk of developing chronic hepatitis B virus is 6%, in general population but can reach 10–20% in HBV/HIV co-infected patients. When compared to ge...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2006
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1468419/ https://www.ncbi.nlm.nih.gov/pubmed/16600028 http://dx.doi.org/10.1186/1742-6405-3-9 |